Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
21m agoSenseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
21m agoUWMC Issues Open Letter to Two Harbors Stockholders Detailing New $12 Per Share Offer
21m agoPershing Square’s Bill Ackman and Ryan Israel to Host a Spaces Event on X
22m agoMcEwen Inc. and Golden Lake Exploration Inc. Announce Closing of Arrangement
1h agoSCENTRE GROUP ANNOUNCES EXPIRATION AND RESULTS OF TENDER OFFER
Polypid logo

Polypid

About

Polypid (NASDAQ:PYPD) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 13 2026
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
Mar 31 2026
PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA
Mar 17 2026
PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application
Feb 25 2026
PolyPid Announces Participation in Upcoming Investor Conferences
Feb 11 2026
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Financials

Revenue
$0
Market Cap
$80.91 M
EPS
-2.09

Community Chat

Ask AI

6ix6ix